Slocum, Gordon & Co’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,942
Closed -$230K 75
2026
Q1
$230K Hold
1,942
0.16% 56
2025
Q4
$244K Hold
1,942
0.18% 55
2025
Q3
$284K Hold
1,942
0.23% 46
2025
Q2
$303K Hold
1,942
0.24% 45
2025
Q1
$320K Hold
1,942
0.24% 43
2024
Q4
$316K Hold
1,942
0.26% 42
2024
Q3
$379K Hold
1,942
0.15% 45
2024
Q2
$337K Hold
1,942
0.25% 43
2024
Q1
$329K Hold
1,942
0.24% 42
2023
Q4
$383K Hold
1,942
0.34% 38
2023
Q3
$338K Hold
1,942
0.29% 40
2023
Q2
$334K Hold
1,942
0.24% 40
2023
Q1
$323K Buy
+1,942
New +$318K 0.27% 40

Other funds holding ZTS

Slocum, Gordon & Co's ZTS Position: Q2 2026 in Review

Slocum, Gordon & Co sold out of Zoetis (ZTS) in Q2 2026, closing a stake of 1,942 shares — an estimated $230K sold.

Slocum, Gordon & Co first reported a position in ZTS in Q1 2023 and held it in 13 quarters. The position peaked at $383K in Q4 2023. 472 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.

  • Slocum, Gordon & Co reported no remaining Zoetis position as of Q2 2026 after selling out during the quarter.
  • Slocum, Gordon & Co sold 1,942 Zoetis shares in Q2 2026, an estimated $230K.
  • Slocum, Gordon & Co first reported a position in Zoetis in Q1 2023 and held it in 13 quarters.
  • Slocum, Gordon & Co's Zoetis position peaked at $383K in Q4 2023.
  • 472 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.

Based on Slocum, Gordon & Co's 13F filing for Q2 2026, filed 23 Jul 2026.